New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ.
from Top Health News – ScienceDaily http://bit.ly/2HfjI9E
from Tumblr http://bit.ly/2K1jVe8
No comments:
Post a Comment